International Journal of Cancer · 1994 · 96 citations · 20 references
MedicineOncologyPathologyCarcinogenesisMolecular OncologyNeoplasiaCancer Molecular PathologyCyclin-dependent KinasesEsophageal CancerGastric CancerMalignant NeoplasmsSquamous Cell CarcinomaCancer-associated Cyclin-dependent KinasesCell Proliferation IndicesCyclin OverexpressionEsophageal PathologyGastric Premalignant LesionsImmunohistochemistry AssaysP53 AbnormalityP53 Mutation
The objective of this study was to quantify the changes in p53 and cyclin D1 protein levels in different stages of human esophageal and gastric cardia carcinogenesis in a high-risk population in Henan, China. Immunoreactivity of p53, cyclin D1 and proliferating-cell nuclear antigen (PCNA) was observed in the cell nuclei of esophageal and gastric cardia biopsies. The number of p53-immunostaining-positive cells was low in normal epithelia, slightly increased in basal-cell hyperplasia (BCH), markedly increased in dysplasia (DYS) (10-fold), and further increased in squamous-cell carcinoma (SCC) (40-fold). This pattern of change was similar to that of cell proliferation as indicated by PCNA immunostaining. On the other hand, the number of cyclin D1-immunostaining-positive cells did not increase from BCH to DYS, although a slight increase from DYS to SCC was noted. In the gastric cardia, again, the pattern of change of p53-positive cells in different stages of lesions paralleled the pattern of cell proliferation. The number of p53-positive cells was very low, much lower than that of PCNA-positive cells, in normal, chronic superficial gastritis (CSG) and chronic atrophic gastritis (CAG); therefore, the increase of p53-positive cells from CAG to DYS was more dramatic (100-fold). From DYS to adenocarcinoma (AC), the p53-positive and the PCNA-positive cells increased 4-fold. On the other hand, the number of cyclin D1-positive cells did not increase in pre-cancerous lesions, but increased slightly in AC. This study demonstrates that p53 protein accumulation increased with the progression of pre-cancerous lesions, especially in the genesis of dysplasia, both in the esophagus and in the gastric cardia. Our approach of quantitative immunohistochemistry sheds light on the mechanisms of genesis of esophageal and gastric-cardia cancers, which frequently occur together in many high-incidence areas.
20
A novel cyclin encoded by a bcl1-linked candidate oncogene
Toru Motokura, Theodora Bloom, Hyung Goo Kim et al. · Nature · 1991 · 1.3K citations
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
Manuel Pera, Alan J. Cameron, Victor F. Trastek et al. · Gastroenterology · 1993 · 869 citations
Research on esophageal cancer in China: a review.
Chung S. Yang · PubMed · 1980 · 667 citations
Amplification and expression of the human cyclin D gene in esophageal cancer.
Wei Jiang, Scott M. Kahn, Naohiro Tomita et al. · PubMed · 1992 · 410 citations
Life Sciences, Genetics, Oncology +10